RT @TxID_Fellows@twitter.com

1/
Welcome to a new monthly series by
@TxID_Fellows@twitter.com, #TxIDProfileTuesday

#TxIDProfileTuesday will highlight a leader in #TxID, sharing why they love #TxID & giving their best advice to trainees!

Come join us for our first #TxIDProfileTuesday featuring @RicardoLaHozMD@twitter.com

🐦🔗: https://twitter.com/TxID_Fellows/status/1618018901929132032

RT @alan_koff@twitter.com

Consider chronic graft pyelo in a kidney TXP pt with:
1) recurrent UTIs or repeat isolation of same bacteria in UCx
2) worsening CKD
3) chronic graft pain (can also be asymptomatic/pauci-symptomatic)
Underdiagnosed. Tx may improve graft outcomes. #TxID. http://doi.org/10.1097/TXD.0000000000001223

🐦🔗: https://twitter.com/alan_koff/status/1607357434292584448

RT @DrAndreKalil@twitter.com

🆕💥
“How to use biomarkers of infection or sepsis at the bedside: Guide to Clinicians"
Pedro Povoa, myself, & great team of coauthors just published this new guide in Intensive Care Medicine
👇
#MedTwitter #IDTwitter #PulmTwitter #TxID #TwitteRx #MedEd
https://bit.ly/3GdS9sT

🐦🔗: https://twitter.com/DrAndreKalil/status/1610030982073315330

RT @TakaMatsuo_ID@twitter.com

【Infectious diarrhea after allogeneic HSCT】IJID Dec 2022 🇧🇪

👉2016-2020, N=140
👉32% at least 1 episode after 1 year
👉C. difficile
👉Adenovirus
👉EPEC
👉Campylobacter jejuni
👉GVHD 3-4 higher risk for a first infectious diarrhea

https://pubmed.ncbi.nlm.nih.gov/36481487/

#TxID

🐦🔗: https://twitter.com/TakaMatsuo_ID/status/1607384276819148801

RT @alan_koff@twitter.com

TMP/SMX prophylaxis is broad spectrum, offering protection against PJP, Toxoplasma, Nocardia, Listeria, UTI (renal TXP). Less expensive and more effective than alternatives. Ensure appropriate dosing, and de-label allergies such as 'nausea'. #TxID. http://doi.org/10.1111/tid.13461

🐦🔗: https://twitter.com/alan_koff/status/1605542852720730115

@davidvanduin @DocWoc71 @ShohamTxID Where the #TXID folks at? #IDMastodon #MedMastodon todon

#IDMastodon #TxID
What is your threshold for giving IVIG to hypogam SOT recipient with active infection?

RT @TxID_Fellows@twitter.com

Join us on Thursday 12/15 at 7:30pm ET/6:30pm CT for our first #TxIDChat. We'll talk about job interviews, early career success and finding work-life balance. #TxID #IDTwitter #MedTwitter

🐦🔗: https://twitter.com/TxID_Fellows/status/1599428344650469377

RT @TxID_Fellows@twitter.com

#IDtwitter: We have some questions ready to go for our first ever #TxIDChat, but it’s been #strange around here lately. We want to discuss job interviews and early career advice. Would you be interested in this #TxIDChat?? #TxID #MedTwitter

🐦🔗: https://twitter.com/TxID_Fellows/status/1597325546362646528

RT @TxID_Fellows@twitter.com

#IDtwitter: We have some questions ready to go for our first ever #TxIDChat, but it’s been #strange around here lately. We want to discuss job interviews and early career advice. Would you be interested in this #TxIDChat?? #TxID #MedTwitter

🐦🔗: https://twitter.com/TxID_Fellows/status/1597325546362646528

Adding links to the chapters "Specific Agents and Risk of Infections" to the "Biologics" folder at http://transplantid.net

It's an all-star case, hope to read it soon!

RT @GermHunterMD@twitter.com

Infectious Complications in Biologic and Targeted Therapies

Edited by Carlos Cervera & Jose María Aguado

https://link.springer.com/book/10.1007/978-3-031-11363-5 #TxID

🐦🔗: https://twitter.com/GermHunterMD/status/1596308078198247424

Since #TxID #TransplantID is so full of #MDRO, this approach may be useful in ill #SOT and #neutropenicfever

So we'll file it in the "MDR GNR" and "Stewardship" folders at http://transplantid.net / http://txpid.net

RT @CIDJournal@twitter.com

Introducing the Escalation Antibiogram: A Simple Tool to Inform Changes in Empiric Antimicrobials in the Nonresponding Patient

🔗 https://bit.ly/3tEFpWa

🐦🔗: https://twitter.com/CIDJournal/status/1595060303922102272

#introduction I am a transplant /oncology infectious diseases physician in Tucson. And I’m medical mycology passionate. #medtwitter #TxID

RT @alfred_luk@twitter.com

#TID2022 virtual congress day 2: Great ⁩presentation and analysis of top papers 🌎 by ⁦@KottonNelson@twitter.com⁩ & ⁦@EmilyBlumbergMD@twitter.com⁩
#TxID #IDTwitter ⁦@ttsorg@twitter.com⁩ ⁦@TransplantIDNet@twitter.com⁩

TTS TID 2022 Virtual Congress - Top Papers of the World https://qxmd.com/r/shared-collection/26747

🐦🔗: https://twitter.com/alfred_luk/status/1593276802474065920

🔥👍 NOV22 OFID: GM-CSF as Adjuvant Immunomodulatory therapy for #IFI in Children 👶: We frequently employ #GCSF & even #Granulocytes 4 #NeutropenicIFI 🍄, but continued use #AfterNeutropenia is new 2 me! But stakes are ⬆️ & 👍 2 see tolerance is 👍 & in line w/our experience. #MoreStudiesPlease #PICHID #TxID

https://t.co/E0MBi5HHpu

🙌 Excited to remeet & #introduce myself to the #Med-Mastodon 🐘 #IDSoMe Community:

🔬🦠🍄 Pediatric Infectious Diseases, passionate about clinical outcomes, infections & advancing care & access for #PICH 👶 Pediatric ImmunoCompromised Hosts, including #TransplantID #OncID & #OI in 1°ID or kids on #ImmunomodulatorTx. Associate Professor & Medical Director of #PediatricTICH ID @UTSouthwestern & @UTSWPedsGroup in #DallasTX, by way of #Montreal #Baltimore & #QueensNY. #PedsID #TxID #DEI #MedToots